Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

118

...

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L01EX01	SUNITINIB AQVIDA	G	Sunitinib maleate - 12.5mg	12.5mg	Capsule, hard	41,692,397 L.L
L01EX01	SUTENT	B	Sunitinib maleate - 25mg	25mg	Capsule	98,852,769 L.L
L01EX01	SOVIDEX	G	Sunitinib maleate - 25mg	25mg	Capsule	64,804,314 L.L
L01EX01	SUTENT	B	Sunitinib maleate - 50mg	50mg	Capsule	197,706,574 L.L
L01EX01	SOVIDEX	G	Sunitinib maleate - 50mg	50mg	Capsule	118,623,323 L.L
L01EX01	SUTENT	B	Sunitinib maleate - 12.5mg	12.5mg	Capsule	L.L
L01EX01	SUNITINIB AQVIDA	G	Sunitinib maleate - 50mg	50mg	Capsule, hard	151,885,541 L.L
L01EX01	SUTENT	B	Sunitinib maleate - 50mg	50mg	Capsule	L.L
L01EX02	NEXAVAR	B	Sorafenib - 200mg	200mg	Tablet, film coated	86,139,938 L.L
L01EX02	NEXAVAR	B	Sorafenib - 200mg	200mg	Tablet, film coated	L.L
L01EX03	VOTRIENT	B	Pazopanib HCl - 400mg	400mg	Tablet, film coated	66,323,011 L.L
L01EX03	VOTRIENT	B	Pazopanib HCl - 400mg	400mg	Tablet, film coated	72,470,021 L.L
L01EX03	VOTRIENT	B	Pazopanib HCl - 200mg	200mg	Tablet, film coated	31,567,504 L.L
L01EX03	VOTRIENT	B	Pazopanib HCl - 200mg	200mg	Tablet, film coated	35,112,293 L.L
L01EX05	STIVARGA	B	Regorafenib - 40mg	40mg	Tablet, film coated	L.L
L01EX05	STIVARGA	B	Regorafenib - 40mg	40mg	Tablet, film coated	272,778,486 L.L
L01EX07	CABOMETYX	B	Cabozantinib - 20mg	20mg	Tablet, film coated	440,893,501 L.L
L01EX07	CABOMETYX	B	Cabozantinib - 40mg	40mg	Tablet, film coated	440,893,501 L.L
L01EX07	CABOMETYX	B	Cabozantinib - 60mg	60mg	Tablet, film coated	440,893,501 L.L
L01EX08	LENVIMA	B	Lenvatinib - 4mg	4mg	Capsule, hard	124,450,304 L.L
L01EX08	LENVIMA	B	Lenvatinib - 10mg	10mg	Capsule, hard	124,450,304 L.L
L01EX08	LENVIMA	B	Lenvatinib - 10mg	10mg	Capsule, hard	L.L
L01EX08	LENVIMA	B	Lenvatinib - 4mg	4mg	Capsule, hard	L.L
L01EX09	OFEV	B	Nintedanib - 100mg	100mg	Capsule, soft	104,970,726 L.L
L01EX09	OFEV	B	Nintedanib - 150mg	150mg	Capsule, soft	209,943,871 L.L
L01EX09	OFEV	B	Nintedanib - 150mg	150mg	Capsule, soft	L.L
L01EX10	RYDAPT	B	Midostaurin - 25mg	25mg	Capsule, soft	1,214,817,915 L.L
L01EX10	RYDAPT	B	Midostaurin - 25mg	25mg	Capsule, soft	607,408,958 L.L
L01FA01	MABIXEN 100	BioTech	Rituximab - 100mg/10ml	100mg/10ml	Injectable concentrate for solution	22,183,393 L.L
L01FA01	MABIXEN 100	BioTech	Rituximab - 100mg/10ml	100mg/10ml	Injectable concentrate for solution	11,091,696 L.L

...

118

...